Intractable Seizure With Hypoglycemia: A Mysterious Retroperitoneal Fibrosarcoma

Ipek Midi, Prof Dr^a; Gazanfer Ekinci, Prof Dr^c; Burcu Bulut Okay, MD^a; Sena Zeynep Cetin, MD^b

Prim Care Companion CNS Disord 2022;24(4):21cr03117

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (6)

Antonescu CR, Erlandson RA, Huvos AG. Primary fibrosarcoma and malignant fibrous histiocytoma of bone–a comparative ultrastructural study: evidence of a spectrum of fibroblastic differentiation. Ultrastruct Pathol. 2000;24(2):83–91. PubMed CrossRef
LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett. 2003;195(2):127–137. PubMed CrossRef
Zapf J, Futo E, Peter M, et al. Can “big” insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest. 1992;90(6):2574–2584. PubMed CrossRef
Fukuda I, Hizuka N, Ishikawa Y, et al. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Growth Horm IGF Res. 2006;16(4):211–216. PubMed CrossRef
Cotterill AM, Holly JM, Davies SC, et al. The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumor-associated hypoglycemia. J Endocrinol. 1991;131(2):303–311. PubMed CrossRef
Alkemade GM, Bakker M, Rikhof B, et al. Hypoglycemia in a patient with a big “big”-IGF-II-producing tumor. J Clin Endocrinol Metab. 2013;98(8):3113–3114. PubMed CrossRef